TrademarkDir
STIMVAX
DEAD

Serial Number

88401890

Owner

MIRROR BIOLOGICS, INC.

Attorney

Z. Peter Sawicki

Filing Date

Apr 25, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

STIMVAX Trademark

Serial Number: 88401890

STIMVAX is a trademark filed by MIRROR BIOLOGICS, INC. on April 25, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

MIRROR BIOLOGICS, INC. (7 trademarks)

2818 Cypress Ridge Blvd, Suite 110
Wesley Chapel, FL 33544

Entity Type: 03

Immunovative Therapies, Ltd. (19 trademarks)

PO Box 974
Shoham 60850 , IL

Entity Type: 16

Trademark Details

Filing Date

April 25, 2019

Registration Date

Not Registered

Published for Opposition

March 12, 2024

Goods & Services

Pharmaceutical preparations for the treatment of proliferative and metastatic diseases

Medical services for treatment of proliferative and metastatic diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 9, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 9, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 5, 2024 EXRA
SOU EXTENSION 1 GRANTED
Nov 5, 2024 EX1G
SOU EXTENSION 1 FILED
Nov 5, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 5, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 7, 2024 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 13, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 13, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 13, 2024 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2024 CRFA
ASSIGNED TO LIE
Feb 5, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 23, 2023 ERSI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 27, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 27, 2023 XELR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 30, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 30, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 30, 2022 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 18, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 7, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 7, 2022 GNSL
SUSPENSION LETTER WRITTEN
Apr 7, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 30, 2022 ERSI
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 20, 2021 ASGN
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 4, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 4, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 4, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 27, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 5, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 5, 2021 GNSL
SUSPENSION LETTER WRITTEN
Mar 5, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 3, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 9, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 9, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 9, 2020 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 20, 2020 RCCK
ASSIGNED TO LIE
Aug 19, 2020 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 21, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 21, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jan 21, 2020 CNSL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2020 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 17, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jul 17, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jul 17, 2019 CNRT
ASSIGNED TO EXAMINER
Jul 8, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2019 NWOS
NEW APPLICATION ENTERED
Apr 29, 2019 NWAP

Related Trademarks

More from this Owner

IMMUNOCARE THERAPIES

IMMUNOCARE THERAPIES

IMMUNOCARE THERAPIES

IMMUNOCARE THERAPIES

IMMUNOCARE

IMMUNOCARE

IMMUNOCARE

IMMUNOCARE

CRYOVAX

CRYOVAX

IMMUNOCARE THERAPIES

IMMUNOCARE THERAPIES